Current Sponsors

» Quantitative Immune Profiling and Immune Monitoring

» Internet of Diagnostic Things

» Immuno-Oncology Biomarkers

» Clinical and Translational Biomarkers

» Digital Biomarkers: Biosensors, Wearables, and mHealth

» Extracellular Vesicles

» 3D Cellular Models

» Preclinical Strategies, Models & Tools in Oncology

» Chemical Biology and Target Validation

» CNS Targets and Translational Strategies

» Optimizing Drug Metabolism & Pharmacokinetics

» iPS Cells for Disease Modeling and Drug Discovery

» Patient-Derived Tumor Organoids

» Target Identification & Phenotypic Screening

» Blood-Brain Barrier

» Predicting Drug Toxicity

» Small Molecules for Immuno-Oncology Therapeutics

» Cancer Immunotherapy Models

» Applying 3D Models

» Quantitative Immune Profiling and Immune Monitoring

» Preclinical Strategies, Models & Tools in Oncology

» Immuno-Oncology Biomarkers

» Immuno-Oncology Clinical Trials Strategy and Execution

» Combination Cancer Immunotherapy

» Patient-Derived Tumor Organoids

» Immuno-Oncology Commercial and Business Strategy

» Emerging Immuno-Oncology Targets and Modalities

» Small Molecules for Immuno-Oncology Therapeutics

» Cancer Immunotherapy Models

» Internet of Diagnostic Things

» Digital Health: Pharmaceutical Executive Summit

» Digital Biomarkers: Biosensors, Wearables, and mHealth